by Caroline Ryan | Oct 5, 2026 | General
The U.S. Army has awarded Anduril Industries a contract worth up to $1.8 billion to move its Next-Generation Command and Control system from large-scale testing toward operational deployment, beginning with I Corps. The award has a base value of $162.8 million, with...
by Benzinga Insights | Oct 5, 2026 | General
Amazon.com (NASDAQ:AMZN) has outperformed the market over the past 15 years by 9.38% on an annualized basis producing an average annual return of 22.64%. Currently, Amazon.com has a market capitalization of $2.70 trillion. Buying $100 In AMZN: If an investor had...
by Erica Kollmann | Oct 5, 2026 | General
A suspected plague death at a Siberian research institute has investors reaching for the pandemic playbook again. One of biotech’s most heavily shorted stocks is posting the biggest gain. Novavax Inc. (NASDAQ:NVAX) shares jumped over 20% on Monday, near their 52-week...
by Benzinga Insights | Oct 5, 2026 | General
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 29.68% on an annualized basis producing an average annual return of 43.44%. Currently, Natera has a market capitalization of $62.06 billion. Buying $1000 In NTRA: If an investor had bought...
by Benzinga Insights | Oct 5, 2026 | General
Twist Bioscience (NASDAQ:TWST) has outperformed the market over the past 5 years by 3.68% on an annualized basis producing an average annual return of 15.78%. Currently, Twist Bioscience has a market capitalization of $13.50 billion. Buying $1000 In TWST: If an...
Recent Comments